Carbamazepine inhibits the potentiation by adenosine analogues of agonist induced inositolphosphate formation in hippocampal astrocyte cultures

Biological Psychiatry

Volumn 40, Issue 7, 1996, Pages 563-567

  Biber, Knut ^a   Walden, Jörg ^a   Gebicke Härter, Peter ^a   Berger, Mathias ^a   Van Calker, Dietrich ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

adenosine A1 receptors; affective disorders; astrocytes; carbamazepine; inositolphosphate calcium signalling; lithium

Indexed keywords

ADENOSINE DERIVATIVE; CARBAMAZEPINE; INOSITOL PHOSPHATE; PHENYLEPHRINE;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL CULTURE; HIPPOCAMPUS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030272949     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(96)00031-5     Document Type: Article

References (18)

1. Baraban JM, Worley PF, Snyder SH (1989): Second messenger systems and psychoactive drug action: Focus on the phosphoinositide system and lithium. Am J Psychiatry 146:1251-1260.
2. Berridge MJ (1993): Inositol trisphosphate and calcium signalling. Nature 361:315-325.
3. Berridge MJ, Irvine RF (1989): Inositol phosphates and cell signalling. Nature 341:197-205.
4. Daval J-L, Deckert J, Weiss SRB, Post RM, Marangos PJ (1989): Upregulation of adenosine A1-receptors and forskolin binding sites following chronic treatment with caffein or carbamazepine. Epilepsia 30:26-31.
5. Dickenson JM, Hill SJ (1994): Interactions between adenosine A1-receptors and histamine H1-receptors. Int J Biochem 26:959-969.
6. Dragunow M (1988): Purinergic mechanisms in epilepsy. Progress in Neurobiology 31:85-108.
7. el Etr M, Cordier J, Torrens Y, Glowinski J, Premont N (1989): Pharmacological and functional heterogenity of astrocytes: Regional differences in phospholipase C stimulation by neuromediators. J Neurochem 52:981-984.
8. Fritze J, Beneke M, Lanczik M, Schneider B, Waiden J (1994): Carbamazepine as adjunct or alternative to lithium in the prophylaxis of recurrent affective disorders. Pharmacopsychiatry 27:181-185.
9. Marangos PJ, Montgomery P, Weiss SRG, Patel J, Post RM (1987): Persistent upregulation of brain adenosine receptors in response to chronic carbamazepine treatment. Clin Neuropharmacol 5:443-448.
10. Marangos PJ, Weiss SRB, Montgomery P, Patel J, Narang PK, Cappabianca AM, Post RM (1985): Chronic carbamazepine treatment increases brain adenosine receptors. Epilepsia 26: 493-498.
11. Post RM (1992): Rapid cycling and depression. In Montgomery SA, Rouillon F (eds), Long-Term Treatment of Depression. New York: John Wiley & Sons, pp 139-195.
12. Post RM (1993): Evaluation of long-term prophylactic treatments of depressive disorders. In Mendlewicz J, Brunello N, Langer SZ, Racagni G (eds), International Academic Biomed Drug Research. Basel: Karger, pp 101-113.
13. Post RM, Susan R, Weiss B (1992): Sensitization, kindling, and carbamazepine: An update on their implications for the course of affective illness. Pharmacopsychiatry 25:41-43.
14. Rudolphi KA, Schubert P, Parkinson FE, Fredholm BB (1992): Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol Sci 13:439-445.
15. Solomon DA, Keitner GI, Miller IW, Shea MT, Keller MB (1995): Course of illness and maintenance treatments for patients with bipolar disorders. J Clin Psychiatry 56:5-13.
16. van Calker D, Assmann K, Greil W (1987): Stimulation by bradykinin, angiotensin II, and carbachol of the accumulation of inositolphosphates in PC-12 Pheochromocytoma cells: Differential effects of lithium ions on inositol mono-and polyphosphates. J Neurochem 49:1379-1385.
17. van Calker D, Steber R, Klotz K, Greil W (1991): Carbamazepine distinguishes between adenosine receptors that mediate different second messenger response. Eur J Pharmacol Mol Pharmac Sect 206:285-290.
18. Williams M (1995): Purinoceptors in central nervous system function. In Bloom FE, Kupfer DJ (eds), Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, pp 643-655.